Cargando…
Immune responses to human factor IX in haemophilia B mice of different genetic backgrounds are distinct and modified by TLR4
Our laboratory develops protocols to prevent or reverse ongoing anti-hFIX IgG inhibitors in haemophilia B mice with a F9 gene deletion on BALB/c and C3H/HeJ backgrounds. C3H/HeJ F9(−/Y) mice develop high titre anti-hFIX IgG1 inhibitors and anaphylaxis, whereas most BALB/c F9(−/Y) mice have mild anti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309508/ https://www.ncbi.nlm.nih.gov/pubmed/25417755 http://dx.doi.org/10.1111/hae.12522 |